Small-cap shares swung widely as exploration results, takeover bids and funding needs drove the week’s biggest moves.
Kaoko plunged while PARKD rallied, showing how quickly thinly traded stocks can change direction.
- Kaoko Metals fell 57.51% despite reporting broad copper-silver grades at Otniel.
- PARKD rose 50% after securing a Symal partnership and an A$800,000 placement.
- EBR Systems dropped 40.43% as quarterly implant volumes declined.
- Resources companies continued to report larger deposits, but many still need drilling, permits or new money.
- Data centre, healthcare and takeover news produced several stronger gains.
Kaoko Metals (ASX:KAO) was the week’s biggest faller, dropping 57.51%. The company reported wide copper and silver zones at Otniel, but the results were early and lacked proof of size, continuity and processing value. Investors sold heavily after the announcement, showing that strong drill grades do not always overcome earlier speculation in a small stock.
PARKD (ASX:PKD) moved the other way, rising 50.00%. Its three-year agreement with Symal gives it a larger route into construction work across Victoria and South Australia. The A$800,000 share sale was priced above the previous market price, which investors read as support from a new commercial partner. The company still needs to win actual projects before the deal produces lasting sales.
EBR Systems (ASX:EBR) fell 40.43% after reporting 40 WiSE implants in the September quarter, down from 46 in the June quarter. September procedures were about half the July-August average. Investors worried that changes in sales staff and strategy are slowing adoption of its heart device. Higher US Medicare payments may help, but only if hospitals order more devices.
Resources bring big numbers, but proof takes time
Resource companies produced some of the week’s most eye-catching results. Power Minerals (ASX:PNN) reported 91 metres at 7.7% total rare earth oxides from surface. Solstice Minerals (ASX:SLS) found wide copper-gold zones outside its current estimate. Sunstone Metals (ASX:STM) lifted its Bramaderos resource to 6.2 million ounces of gold equivalent. These figures can support future mine studies, but drilling, recovery tests and permits must come first.
Several companies also moved closer to development. KGL Resources (ASX:KGL) approved construction of Jervois, with first copper targeted for the first half of 2028. Grange Resources (ASX:GRR) committed A$287 million to keep Savage River operating until at least 2035. Core Lithium (ASX:CXO) produced its first spodumene concentrate at Finniss. Each project now faces a practical test: build the plant, control costs and produce saleable material.
Healthcare gains came with cash questions
Mesoblast (ASX:MSB) reported US$115.2 million in Ryoncil sales and completed treatment in its 350-patient back-pain trial. The commercial launch is a clear improvement, but the company remains loss-making and expects to need more money beyond the next year. Acrux (ASX:ACR) gained 9.09% after the US regulator accepted the planned design for two late-stage trials of its testosterone spray. NeuroScientific Biopharmaceuticals (ASX:NSB) also received support for most of its proposed Crohn’s disease trial design.
Not every healthcare update was positive. Bubs Australia (ASX:BUB) grew sales and secured permanent US approval for its infant formula, yet used A$15.1 million in operating cash and still faces questions about ongoing funding. Vitura Health (ASX:VIT) grew revenue but posted a A$4.4 million loss, with debt due within a year. These companies must turn regulatory progress or sales growth into steady cash before investors can rely on the recovery.
Deals and infrastructure reshape the board
Corporate transactions also drove large moves. Crimson lifted its offer for Kip McGrath Education Centres (ASX:KME) to 75 cents a share and removed the bid’s conditions, leaving acceptances as the main issue before 19 October. Warburg Pincus made its A$5.25 proposal for Ingenia Communities (ASX:INA) best and final unless a higher bid appears, but the offer remains non-binding. SkyCity Entertainment Group (ASX:SKC) signed a conditional A$221 million hotel sale, with the proceeds intended to repay debt.
Data centre spending remained strong. DigiCo Infrastructure REIT (ASX:DGT) secured a 15-year, 71-megawatt contract that fills its Sydney campus. SHAPE Australia (ASX:SHA) won an approximately A$800 million expansion contract for the same campus. The contracts provide visible work, but investors will still watch construction costs, delivery dates and the returns earned on the new capacity.
Elsewhere, WiseTech Global (ASX:WTC) rose 11.83% after reporting strong growth from the e2open acquisition and its artificial intelligence programme. The company also removed about 1,700 roles and carried net debt of US$2.2 billion. Glencore (ASX:GLC) continued its shift towards copper while coal earnings weakened. The common thread is clear: investors rewarded growth plans, but debt, regulation and delivery remain the main tests.
Bottom Line?
The next week should turn attention to takeover deadlines, project approvals, drilling results and early production updates. Investors will need to separate reported resources and signed contracts from revenue and cash that have actually arrived.
Questions in the middle?
- Will Kaoko Metals recover after its sharp fall, or will investors keep selling until drilling proves the copper zones are continuous?
- Can EBR Systems restore implant volumes after its sales reset, and will higher US Medicare payments change hospital demand?
- Will the proposed takeovers of Kip McGrath and Ingenia reach binding outcomes before their stated deadlines?
Sources
This wrap draws on announcements from 27 companies. For the full story and each verified source, see the company's own article:
ASX:ACR, ASX:AEG, ASX:BUB, ASX:BUY, ASX:CXO, ASX:DGT, ASX:EBR, ASX:FTI, ASX:GLC, ASX:GRR, ASX:GSE, ASX:HAR, ASX:INA, ASX:IXR, ASX:KAO, ASX:KGL, ASX:KME, ASX:MSB, ASX:NSB, ASX:PKD, ASX:PNN, ASX:SHA, ASX:SLS, ASX:STM, ASX:VIT, ASX:WTC, NZX:SKC